NCT00280982View on ClinicalTrials.gov

Dendritic Cell-based Immunotherapy in Mesothelioma

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Malignant Pleural Mesothelioma
Interventions
BIOLOGICAL

tumor lysate-loaded autologous dendritic cells

50x10e6 cells per vaccination, 3 times, 2 weeks interval

Trial Locations (1)

3015 GE

Department of Pulmonary Medicine, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER